Infusion-Related Reactions (IRRs) with Ublituximab in Patients with Relapsing Multiple Sclerosis (RMS): Post Hoc Analyses from the Phase 3 ULTIMATE I and II Studies

Drug Category : Array
Conference Category : Array
Lead Author : Fox E, et al.
Published Date : 03/04/2022
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2022/04/Fox_IRRs_AAN_2022.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top